Therapy related acute myeloid leukemia with t(10:16): a rare entity

Treatment related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML) are well known complications after chemotherapy for various hematologic and non-hematologic malignancies. Alkylating agents and Topoisomerase inhibitors are most widely studied in this regard. There is growing conc...

Full description

Bibliographic Details
Published in:	Hematology Reports
Main Authors:	Guldeep K. Uppal, John Leighton, Deline Da Costa, Andrew Czulewicz, Irma E. Palazzo
Format:	Article
Language:	English
Published:	MDPI AG 2011-12-01
Subjects:	acute myeloid leukemia, myelodysplastic syndrome.
Online Access:	http://www.pagepress.org/journals/index.php/hr/article/view/3289

Similar Items

Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia
by: Shyam A. Patel, et al.
Published: (2024-10-01)

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases
by: Yenny Alejandra Moreno Vanegas, et al.
Published: (2018-09-01)

Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
by: İbrahim Ethem Pınar, et al.
Published: (2021-03-01)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2022-06-01)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01)

Clinico-hematological and Cytogenetic Study of Myeloid Neoplasms: A cross-sectional Study from South India
by: Nidhi Nair, et al.
Published: (2025-01-01)

The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis
by: Yufeng Du, et al.
Published: (2023-12-01)

Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Katie Culos, et al.
Published: (2019-05-01)

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Yasmin Abaza, et al.
Published: (2022-07-01)

Cytogenetic profile and risk of transformation to acute myeloid leukemia (AML) in Indonesian patients with myelodysplastic syndrome (MDS): a pilot study [version 1; peer review: 2 approved]
by: Yuniar Harris Prayitno, et al.
Published: (2024-03-01)

The consequences of cohesin mutations in myeloid malignancies
by: Shubhra Ashish Bhattacharya, et al.
Published: (2023-11-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

New SAMD9L heterozygous mutation leading to myelodysplastic syndrome and acute myeloid leukemia: A case report and review of the literature
by: Dania A. Monagel
Published: (2023-04-01)

Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
by: Xuefeng Li, et al.
Published: (2022-08-01)

Liquid biopsies and minimal residual disease in myeloid malignancies
by: Sabine Allam, et al.
Published: (2023-05-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
by: Shyam A. Patel, et al.
Published: (2023-11-01)

The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status – a Danish nation-wide cohort study
by: Emelie C. Rotbain, et al.
Published: (2025-05-01)

<i>WT1</i> Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Valentina Giudice, et al.
Published: (2021-04-01)

MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
by: Stephanie Rebecca Setijono, et al.
Published: (2018-01-01)

Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges
by: Yuhang Xue, et al.
Published: (2024-02-01)

A rare presentation of bilateral ophthalmic relapse of pediatric chronic myeloid leukemia: Multimodal imaging and treatment
by: Gaurav Garg, et al.
Published: (2023-01-01)

Identification of common hub genes and construction of immune regulatory networks in aplastic anemia, myelodysplastic syndromes, and acute myeloid leukemia
by: Mingliang Shan, et al.
Published: (2025-05-01)

What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01)

Diagnostic Problems in Chronic Basophilic Leukemia
by: Cavit Çehreli
Published: (2018-11-01)

The sweet symphony of N-glycans in myeloid malignancies
by: Javier Sanmartín-Martínez, et al.
Published: (2024-07-01)

A Rare Presentation of Myeloid Sarcoma as Supraclavicular Mass: A Case Report in Chronic Myeloid Leukemia
by: Amna Khan, et al.
Published: (2025-09-01)

Atypical chronic myeloid leukemia found in a patient with eosinophilia for six years: a case report
by: Moqin Jiang, et al.
Published: (2024-07-01)

Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2025-01-01)

Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024-09-01)

Phenotypic and functional changes of NK cells in patients with myelodysplastic syndrome and acute myeloid leukemia treated with hypomethylating drugs
by: D. I. Zhigarev, et al.
Published: (2021-05-01)

Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum‐based chemotherapy
by: Kousei Nakatsuru, et al.
Published: (2023-08-01)

The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
by: Lap Shu Alan Chan, et al.
Published: (2021-05-01)

Difficulties in the differential diagnosis of myelodysplastic syndrome and acute leukemia
by: Alina V. Maltseva, et al.
Published: (2023-05-01)

Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis
by: Frontiers Production Office
Published: (2023-05-01)

Laboratory diagnostics stages of myelodysplastic syndrome transformation into acute erythroid leukemia (clinical case report)
by: I. E. Volgina
Published: (2022-01-01)

Landscape of biallelic DNMT3A mutant myeloid neoplasms
by: Naomi Kawashima, et al.
Published: (2024-09-01)

Acute Myeloid Leukemia: analysis of epidemiological profile and survival rate
by: Mariana Cardoso de Lima, et al.
Published: (2016-05-01)

Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms
by: Qiang Ma, et al.
Published: (2024-12-01)

Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024
by: Weijie Cao, et al.
Published: (2025-04-01)